BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10354917)

  • 1. [Ehlers-Danlos syndrome].
    Brinckmann J; Behrens P; Brenner R; Bätge B; Tronnier M; Wolff HH
    Hautarzt; 1999 Apr; 50(4):257-65. PubMed ID: 10354917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ehlers-Danlos syndromes.
    Yeowell HN; Pinnell SR
    Semin Dermatol; 1993 Sep; 12(3):229-40. PubMed ID: 8217561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ehlers-Danlos syndromes. Clinical, genetic and molecular aspects].
    Germain D
    Ann Dermatol Venereol; 1995; 122(4):187-204. PubMed ID: 8526413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral gene transfer restores lysyl hydroxylase activity in type VI Ehlers-Danlos syndrome.
    Rauma T; Kumpumäki S; Anderson R; Davidson BL; Ruotsalainen H; Myllylä R; Hautala T
    J Invest Dermatol; 2001 Apr; 116(4):602-5. PubMed ID: 11286629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ehlers-Danlos syndrome IV: phenotype variation].
    Engels CH; van Dongen PW; Boers GH; Steijlen PM; Hamel BC
    Ned Tijdschr Geneeskd; 1997 Feb; 141(6):296-8. PubMed ID: 9148166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ehlers-Danlos syndrome associated with glycosaminoglycan abnormalities.
    Miyake N; Kosho T; Matsumoto N
    Adv Exp Med Biol; 2014; 802():145-59. PubMed ID: 24443026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
    Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
    Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen.
    Narcisi P; Richards AJ; Ferguson SD; Pope FM
    Hum Mol Genet; 1994 Sep; 3(9):1617-20. PubMed ID: 7833919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito.
    Toriello HV; Glover TW; Takahara K; Byers PH; Miller DE; Higgins JV; Greenspan DS
    Nat Genet; 1996 Jul; 13(3):361-5. PubMed ID: 8673139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.
    Yeowell HN; Walker LC
    Mol Genet Metab; 2000; 71(1-2):212-24. PubMed ID: 11001813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ehlers-Danlos syndrome: recent advances and current understanding of the clinical and genetic heterogeneity.
    Byers PH
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):47S-52S. PubMed ID: 7963684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of muscular hypotonia in infants: the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VI).
    Yiş U; Dirik E; Chambaz C; Steinmann B; Giunta C
    Neuromuscul Disord; 2008 Mar; 18(3):210-4. PubMed ID: 18155911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostics and classification.
    Hausser I; Anton-Lamprecht I
    Hum Genet; 1994 Apr; 93(4):394-407. PubMed ID: 8168810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular aspects of the Ehlers-Danlos Syndromes.
    Malfait F
    Matrix Biol; 2018 Oct; 71-72():380-395. PubMed ID: 29709596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Ehlers-Danlos syndrome type III and type IV].
    Roqué MH; Roqué CM
    Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):132-5. PubMed ID: 19928404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ehlers-Danlos syndromes].
    Germain DP
    Ann Dermatol Venereol; 2017 Dec; 144(12):744-758. PubMed ID: 29032848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The orodental findings in the Ehlers-Danlos syndrome. A report of 2 clinical cases].
    Majorana A; Facchetti F
    Minerva Stomatol; 1992 Mar; 41(3):127-33. PubMed ID: 1508122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Collagen type I, III, IV and V and fibronectin in skin biopsies of patients with Ehlers-Danlos syndrome and cutis laxa].
    Shekhonin BV; Semiachkina AN; Makkaev KhM; Domogatskiĭ SP; Idel'son GL
    Arkh Patol; 1988; 50(12):41-8. PubMed ID: 3074749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ehlers-Danlos syndromes, rare types.
    Brady AF; Demirdas S; Fournel-Gigleux S; Ghali N; Giunta C; Kapferer-Seebacher I; Kosho T; Mendoza-Londono R; Pope MF; Rohrbach M; Van Damme T; Vandersteen A; van Mourik C; Voermans N; Zschocke J; Malfait F
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):70-115. PubMed ID: 28306225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.